Matthew Gline - Director, 10%+ Owner at Arbutus Biopharma Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Issuer Symbol
ABUS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew Gline since 03 Mar 2025

Holdings reported by Matthew Gline for Arbutus Biopharma Corp

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 38,847,462 $127,536,218 $3.28 24 Feb 2025 By Roivant Sciences Ltd.

There are no transactions reported by Matthew Gline for Arbutus Biopharma Corp